Gaviscon forte suspension for pregnant women 10ml, No. 12

Gaviscon forte suspension for pregnant women 10ml, No. 12; 'Symptomatic treatment of dyspepsia associated with increased acidity of gastric juice and gastroesophageal reflux (heartburn, acid belching), a feeling of heaviness in the stomach after eating, including during pregnancy.

Inside.

Adults and children over 12 years old: 5-10 ml after meals and before bedtime. The maximum daily dose is 40 ml. Using the sachets: Before opening the sachet, remember it with your fingers, stirring the contents. You should not use the drug for a long time, if symptoms persist after 7 days of taking the drug, you should consult a doctor to review therapy.

10 ml of suspension contains:

active ingredients: sodium alginate 1000 mg, potassium bicarbonate 200 mg;

Excipients:

oral suspension [anise]: calcium carbonate 200 mg, carbomer 40 mg, methyl parahydroxybenzoate 40 mg, propyl parahydroxybenzoate 6 mg, sodium hydroxide 14.44 mg, sodium saccharinate 10 mg, fennel flavor 7 mg, purified water up to 10 ml;

suspension for oral administration [mint]: calcium carbonate 200 mg, carbomer 40 mg, methyl parahydroxybenzoate 40 mg, propyl parahydroxybenzoate 6 mg, sodium hydroxide 14.44 mg, sodium saccharinate 10 mg, mint flavor 6 mg, purified water up to 10 ml.

Х hypersensitivity to any component of the drug;

Х children under 12 years of age.

Carefully:

In the presence of the following diseases or conditions, before using the drug, you should consult a doctor: hypercalcemia, nephrocalcinosis and urolithiasis with the formation of calcium oxalate stones, congestive heart failure, renal failure of mild severity.

Application during pregnancy and breastfeeding:

Clinical studies involving more than 500 pregnant women and the amount of data obtained in the post-registration period did not show congenital, fetal and neonatal toxicity of the active substances. GavisconЃ forte can be used during pregnancy if clinically necessary. The effect of the active ingredients of the drug on newborns and infants has not been demonstrated. GavisconЃ forte can be used during breastfeeding.

Pharmacology.

When taken orally, the active ingredients of GavisconЃ forte react quickly with the acidic contents of the stomach. This forms an alginate gel with a pH value close to neutral. The gel forms a protective barrier on the surface of the stomach contents, preventing gastroesophageal reflux (reflux of stomach contents back into the esophagus) for up to four hours. In severe cases of reflux (regurgitation), the gel enters the esophagus ahead of the rest of the gastric contents, where it reduces irritation of the esophageal mucosa. A decrease in irritation is felt 3-4 minutes after ingestion.

Pharmacokinetics:

The mechanism of action of the drug GavisconЃ forte is physical and does not depend on absorption into the systemic circulation.

Special instructions:

In 10 ml of the suspension, the sodium content is 106 mg (4.6 mmol). This should be taken into account when it is necessary to adhere to a diet with limited salt content, for example, with congestive heart failure and renal failure of mild severity. In 10 ml of the suspension, the potassium content is 78 mg (2.0 mmol). Caution must be exercised when treating patients with mild renal impairment, when it is necessary to adhere to a diet with limited potassium content, and when taking medications that can increase the level of potassium in the blood plasma. In 10 ml of the suspension, the content of calcium carbonate is 200 mg (2.0 mmol). The drug should be taken with caution in patients with hypercalcemia, nephrocalcinosis and urolithiasis with the formation of calcium oxalate stones.The drug contains methyl parahydroxybenzoate and propyl parahydroxybenzoate, therefore it can cause allergic reactions (including delayed ones). The drug does not affect the ability to drive vehicles and mechanisms, as well as to engage in other potentially hazardous activities that require increased concentration of attention and speed of psychomotor reactions.

Side effect:

The assessment of the incidence of adverse reactions was made on the basis of the following criteria: very often (? 1/10), often (? 1/100, <1/10), infrequently (? 1/1000, <1/100), rarely (? 1 / 10000, <1/1000), very rare (<1/10000) and unspecified frequency (frequency cannot be calculated from available data). Immune system disorders: of unknown frequency - anaphylactic and anaphylactoid reactions, hypersensitivity reactions (urticaria). Disturbances from the respiratory system, chest and mediastinal organs: of unknown frequency - respiratory effects (bronchospasm). If any of the side effects indicated in the instructions are aggravated, or you notice any other side effects that are not indicated in the instructions, inform your doctor.

Overdose:

Symptoms: Abdominal bloating may occur. Treatment: symptomatic.

Interaction with other medicinal products:

Since calcium carbonate, which is part of the drug, exhibits antacid activity, at least 2 hours should pass between taking GavisconЃ Forte and other drugs, especially when taken simultaneously with H2-histamine receptor blockers, antibiotics from the tetracycline group, digoxin, fluoroquinolone , iron salts, ketoconazole, neuroleptics, thyroid hormones, levothyroxine sodium, penicillamine, beta-blockers (atenolol, metoprolol, propranolol), glucocorticosteroids, chloroquine, bisphosphonates and estramustine.